Dashboard
1
Poor long term growth as Net Sales has grown by an annual rate of 21.96% and Operating profit at -6.75% over the last 5 years
2
The company has declared Positive results for the last 3 consecutive quarters
3
With ROE of 12.88%, it has a fair valuation with a 9.24 Price to Book Value
4
Below par performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
27.84%
0%
27.84%
6 Months
30.76%
0%
30.76%
1 Year
105.54%
0%
105.54%
2 Years
12.45%
0%
12.45%
3 Years
-11.13%
0%
-11.13%
4 Years
-33.38%
0%
-33.38%
5 Years
38.13%
0%
38.13%
Landfar Bio-medicine Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
21.96%
EBIT Growth (5y)
-6.75%
EBIT to Interest (avg)
-7.20
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.69
Sales to Capital Employed (avg)
0.52
Tax Ratio
4.17%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.03%
ROE (avg)
12.39%
Valuation key factors
Factor
Value
P/E Ratio
67
Industry P/E
Price to Book Value
8.63
EV to EBIT
148.32
EV to EBITDA
55.64
EV to Capital Employed
7.64
EV to Sales
4.74
PEG Ratio
0.29
Dividend Yield
NA
ROCE (Latest)
5.15%
ROE (Latest)
12.88%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
Jun'26
Mar'26
Change(%)
Net Sales
176.60
119.30
48.03%
Operating Profit (PBDIT) excl Other Income
-10.90
16.60
-165.66%
Interest
1.90
2.40
-20.83%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-10.20
11.10
-191.89%
Operating Profit Margin (Excl OI)
-89.20%
98.50%
-18.77%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2026 is 48.03% vs -64.12% in Mar 2026
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2026 is -191.89% vs -47.64% in Mar 2026
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
413.30
133.50
209.59%
Operating Profit (PBDIT) excl Other Income
28.70
-8.10
454.32%
Interest
2.80
1.80
55.56%
Exceptional Items
-0.20
-0.00
Consolidate Net Profit
18.10
-23.90
175.73%
Operating Profit Margin (Excl OI)
-6.30%
-194.40%
18.81%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 209.59% vs -1.55% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 175.73% vs 48.93% in Dec 2024
About Landfar Bio-medicine Co., Ltd. 
Landfar Bio-medicine Co., Ltd.
Retailing
No Details Available.
Company Coordinates 
No Company Details Available
Footer loading






